Eupraxia Pharmaceuticals ... (EPRX)
NASDAQ: EPRX
· Real-Time Price · USD
5.34
-0.06 (-1.11%)
At close: Sep 04, 2025, 3:59 PM
5.66
5.99%
After-hours: Sep 04, 2025, 07:21 PM EDT
-1.11% (1D)
| Bid | 5.15 |
| Market Cap | 191.91M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -28.96M |
| EPS (ttm) | -0.86 |
| PE Ratio (ttm) | -6.21 |
| Forward PE | -6.15 |
| Analyst | Buy |
| Ask | 5.66 |
| Volume | 20,203 |
| Avg. Volume (20D) | 11,612 |
| Open | 5.45 |
| Previous Close | 5.40 |
| Day's Range | 5.30 - 5.45 |
| 52-Week Range | 2.20 - 6.20 |
| Beta | 1.54 |
About EPRX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol EPRX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for EPRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
+1.49%
Eurpraxia Pharmaceuticals shares are trading highe...
Unlock content with
Pro Subscription
6 months ago
+10.37%
Eupraxia Pharmaceuticals shares are trading higher after the company reported its trial data results for eosinophilic esophagitis treatment.